# Sidus Space Inc.: financial statements, quarterly

SIDU · Nasdaq · CIK 1879726 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sidu.md) · [Financials](/companies/sidu/financials.md) · [Filings](/companies/sidu/filings.md) · [Insiders](/companies/sidu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sidu/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.8](/filings/0001493152-24-045883.md) | [1.2 d](/filings/0001641172-25-001742.md) | [0.8](/filings/0001641172-25-010989.md) | [0.8](/filings/0001641172-25-024043.md) | [1.8](/filings/0001493152-25-023543.md) | [0.4 d](/filings/0001493152-26-014547.md) | [0.2](/filings/0001493152-26-023709.md) | [0.7](/filings/0001493152-26-037731.md) | [0.6](/filings/0001493152-25-023543.md) | [0.4 d](/filings/0001493152-26-014547.md) | [0.3](/filings/0001493152-26-023709.md) | [0.5](/filings/0001493152-26-037731.md) |
| Cost of revenue | $m | [1.1](/filings/0001493152-24-045883.md) | [1.0 d](/filings/0001641172-25-001742.md) | [1.0](/filings/0001641172-25-010989.md) | [1.8](/filings/0001641172-25-024043.md) | [1.8](/filings/0001493152-25-023543.md) | [1.6 d](/filings/0001493152-26-014547.md) | [1.9](/filings/0001493152-26-023709.md) | [2.3](/filings/0001493152-26-037731.md) | [2.6](/filings/0001493152-25-023543.md) | [2.3 d](/filings/0001493152-26-014547.md) | [1.4](/filings/0001493152-26-023709.md) | [1.2](/filings/0001493152-26-037731.md) |
| Gross profit | $m | [(0.1)](/filings/0001493152-24-045883.md) | [0.3 d](/filings/0001641172-25-001742.md) | [0.1](/filings/0001641172-25-010989.md) | [(0.8)](/filings/0001641172-25-024043.md) | [0.0](/filings/0001493152-25-023543.md) | [(0.8) d](/filings/0001493152-26-014547.md) | [(1.6)](/filings/0001493152-26-023709.md) | [(1.0)](/filings/0001493152-26-037731.md) | [(1.3)](/filings/0001493152-25-023543.md) | [(1.7) d](/filings/0001493152-26-014547.md) | [(1.1)](/filings/0001493152-26-023709.md) | [(0.6)](/filings/0001493152-26-037731.md) |
| Selling, general and administrative | $m | [3.8](/filings/0001493152-24-045883.md) | [3.3 d](/filings/0001641172-25-001742.md) | [3.6](/filings/0001641172-25-010989.md) | [3.1](/filings/0001641172-25-024043.md) | [3.2](/filings/0001493152-25-023543.md) | [4.3 d](/filings/0001493152-26-014547.md) | [4.4](/filings/0001493152-26-023709.md) | [4.3](/filings/0001493152-26-037731.md) | [4.3](/filings/0001493152-25-023543.md) | [9.3 d](/filings/0001493152-26-014547.md) | [4.4](/filings/0001493152-26-023709.md) | [5.1](/filings/0001493152-26-037731.md) |
| Operating income | $m | [(3.9)](/filings/0001493152-24-045883.md) | [(3.0) d](/filings/0001641172-25-001742.md) | [(3.6)](/filings/0001641172-25-010989.md) | [(3.9)](/filings/0001641172-25-024043.md) | [(3.2)](/filings/0001493152-25-023543.md) | [(5.1) d](/filings/0001493152-26-014547.md) | [(6.1)](/filings/0001493152-26-023709.md) | [(5.3)](/filings/0001493152-26-037731.md) | [(5.6)](/filings/0001493152-25-023543.md) | [(11.0) d](/filings/0001493152-26-014547.md) | [(5.5)](/filings/0001493152-26-023709.md) | [(5.7)](/filings/0001493152-26-037731.md) |
| Interest expense | $m | [0.2](/filings/0001493152-24-045883.md) | [0.2 d](/filings/0001641172-25-001742.md) | [0.2](/filings/0001641172-25-010989.md) | [0.2](/filings/0001641172-25-024043.md) | [0.6](/filings/0001493152-25-023543.md) | [0.3 d](/filings/0001493152-26-014547.md) | [0.1](/filings/0001493152-26-023709.md) | [0.0](/filings/0001493152-26-037731.md) | [0.0](/filings/0001493152-25-023543.md) | [0.1 d](/filings/0001493152-26-014547.md) | [0.0](/filings/0001493152-26-023709.md) | [0.0](/filings/0001493152-26-037731.md) |
| Net income | $m | [(4.1)](/filings/0001493152-24-045883.md) | [(3.3) d](/filings/0001641172-25-001742.md) | [(3.8)](/filings/0001493152-25-023543.md) | [(4.1)](/filings/0001493152-25-023543.md) | [(3.9)](/filings/0001493152-25-023543.md) | [(5.7) d](/filings/0001493152-26-014547.md) | [(6.4)](/filings/0001493152-26-037731.md) | [(5.6)](/filings/0001493152-26-037731.md) | [(6.0)](/filings/0001493152-25-023543.md) | [(11.4) d](/filings/0001493152-26-014547.md) | [(5.2)](/filings/0001493152-26-037731.md) | [(4.8)](/filings/0001493152-26-037731.md) |
| Diluted EPS | $ per share | [(5.49)](/filings/0001493152-24-045883.md) | not reported | [(1.42)](/filings/0001641172-25-010989.md) | [(0.99)](/filings/0001641172-25-024043.md) | [(0.93)](/filings/0001493152-25-023543.md) | not reported | [(0.35)](/filings/0001493152-26-023709.md) | [(0.31)](/filings/0001493152-26-037731.md) | [(0.24)](/filings/0001493152-25-023543.md) | not reported | [(0.08)](/filings/0001493152-26-023709.md) | [(0.06)](/filings/0001493152-26-037731.md) |
| Basic EPS | $ per share | [(5.49)](/filings/0001493152-24-045883.md) | not reported | [(1.42)](/filings/0001641172-25-010989.md) | [(0.99)](/filings/0001641172-25-024043.md) | [(0.93)](/filings/0001493152-25-023543.md) | not reported | [(0.35)](/filings/0001493152-26-023709.md) | [(0.31)](/filings/0001493152-26-037731.md) | [(0.24)](/filings/0001493152-25-023543.md) | not reported | [(0.08)](/filings/0001493152-26-023709.md) | [(0.06)](/filings/0001493152-26-037731.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.6](/filings/0001493152-23-041195.md) | [1.2](/filings/0001641172-25-001742.md) | [6.2](/filings/0001493152-24-020795.md) | [1.4](/filings/0001493152-24-033082.md) | [1.2](/filings/0001493152-24-045883.md) | [15.7](/filings/0001493152-26-014547.md) | [11.7](/filings/0001641172-25-010989.md) | [3.6](/filings/0001641172-25-024043.md) | [12.7](/filings/0001493152-25-023543.md) | [43.2](/filings/0001493152-26-037731.md) | [27.3](/filings/0001493152-26-023709.md) | [167](/filings/0001493152-26-037731.md) |
| Current assets | $m | [9.9](/filings/0001493152-23-041195.md) | [9.2](/filings/0001641172-25-001742.md) | [13.3](/filings/0001493152-24-020795.md) | [8.3](/filings/0001493152-24-033082.md) | [9.2](/filings/0001493152-24-045883.md) | [22.3](/filings/0001493152-26-014547.md) | [16.5](/filings/0001641172-25-010989.md) | [11.2](/filings/0001641172-25-024043.md) | [21.1](/filings/0001493152-25-023543.md) | [50.7](/filings/0001493152-26-037731.md) | [33.2](/filings/0001493152-26-023709.md) | [173](/filings/0001493152-26-037731.md) |
| Total assets | $m | [17.8](/filings/0001493152-23-041195.md) | [19.4](/filings/0001641172-25-001742.md) | [25.4](/filings/0001493152-24-020795.md) | [21.8](/filings/0001493152-24-033082.md) | [23.1](/filings/0001493152-24-045883.md) | [37.7](/filings/0001493152-26-014547.md) | [34.0](/filings/0001641172-25-010989.md) | [29.7](/filings/0001641172-25-024043.md) | [39.9](/filings/0001493152-25-023543.md) | [66.1](/filings/0001493152-26-037731.md) | [51.6](/filings/0001493152-26-023709.md) | [195](/filings/0001493152-26-037731.md) |
| Current liabilities | $m | [9.3](/filings/0001493152-23-041195.md) | [12.2](/filings/0001641172-25-001742.md) | [8.2](/filings/0001493152-24-020795.md) | [8.7](/filings/0001493152-24-033082.md) | [13.8](/filings/0001493152-24-045883.md) | [14.2](/filings/0001493152-26-014547.md) | [14.2](/filings/0001641172-25-010989.md) | [14.8](/filings/0001641172-25-024043.md) | [15.4](/filings/0001493152-25-023543.md) | [15.0](/filings/0001493152-26-037731.md) | [3.9](/filings/0001493152-26-023709.md) | [5.2](/filings/0001493152-26-037731.md) |
| Total liabilities | $m | [9.3](/filings/0001493152-23-041195.md) | [12.2](/filings/0001641172-25-001742.md) | [8.2](/filings/0001493152-24-020795.md) | [8.7](/filings/0001493152-24-033082.md) | [13.8](/filings/0001493152-24-045883.md) | [14.2](/filings/0001493152-26-014547.md) | [14.2](/filings/0001641172-25-010989.md) | [15.4](/filings/0001641172-25-024043.md) | [15.9](/filings/0001493152-25-023543.md) | [15.5](/filings/0001493152-26-037731.md) | [4.2](/filings/0001493152-26-023709.md) | [6.0](/filings/0001493152-26-037731.md) |
| Shareholders' equity | $m | [8.5](/filings/0001493152-24-045883.md) | [7.1](/filings/0001493152-26-014547.md) | [17.2](/filings/0001493152-25-023543.md) | [13.1](/filings/0001493152-25-023543.md) | [9.3](/filings/0001493152-25-023543.md) | [23.5](/filings/0001493152-26-037731.md) | [19.8](/filings/0001493152-26-037731.md) | [14.3](/filings/0001493152-26-037731.md) | [24.0](/filings/0001493152-25-023543.md) | [50.6](/filings/0001493152-26-037731.md) | [47.4](/filings/0001493152-26-037731.md) | [189](/filings/0001493152-26-037731.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,816) d](/filings/0001493152-24-045883.md) | [(1,794) d](/filings/0001641172-25-001742.md) | [(5,418)](/filings/0001641172-25-010989.md) | [(2,152) d](/filings/0001641172-25-024043.md) | [(2,718) d](/filings/0001493152-25-023543.md) | [(5,537) d](/filings/0001493152-26-014547.md) | [(3,207)](/filings/0001493152-26-023709.md) | [(4,638) d](/filings/0001493152-26-037731.md) | [(6,220) d](/filings/0001493152-25-023543.md) | [(4,088) d](/filings/0001493152-26-014547.md) | [(5,645)](/filings/0001493152-26-023709.md) | [(3,465) d](/filings/0001493152-26-037731.md) |
| Capital expenditure | $k | [2,222 d](/filings/0001493152-24-045883.md) | [2,372 d](/filings/0001641172-25-001742.md) | [2,230](/filings/0001641172-25-010989.md) | [1,838 d](/filings/0001641172-25-024043.md) | [1,035 d](/filings/0001493152-25-023543.md) | [2,372 d](/filings/0001493152-26-014547.md) | [2,978](/filings/0001493152-26-023709.md) | [1,376 d](/filings/0001641172-25-024043.md) | [1,436 d](/filings/0001493152-25-023543.md) | [2,385 d](/filings/0001493152-26-014547.md) | [3,688](/filings/0001493152-26-023709.md) | [3,647 d](/filings/0001493152-26-037731.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.2](/filings/0001493152-23-041195.md) | [0.3](/filings/0001493152-24-020795.md) | [0.5](/filings/0001493152-24-033082.md) | [0.7](/filings/0001493152-24-045883.md) | [2.7](/filings/0001641172-25-010989.md) | [4.2](/filings/0001641172-25-024043.md) | [4.2](/filings/0001493152-25-023543.md) | [18.2](/filings/0001493152-26-023709.md) | [18.3](/filings/0001493152-26-037731.md) | [24.9](/filings/0001493152-25-023543.md) | [66.6](/filings/0001493152-26-023709.md) | [85.3](/filings/0001493152-26-037731.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,992,952 at 2022-11-14, from the cover of the [10-Q/A filed 2022-12-08](/filings/0001493152-22-034823.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.